Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5271-5276

  Li, Hanfen ^a   Nookala, Suba ^a   Re, Fabio ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; ALUMINUM POTASSIUM SULFATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPEPTIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 34247106805     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5271     Document Type: Article

References (30)

1. + T cells. J. Immunol. 162: 3256-3262.
2. Pulendran, B., and R. Ahmed. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124: 849-863.
3. Gupta, R. K., E. H. Relyveld, E. B. Lindblad, B. Bizzini, S. Ben-Efraim, and C. K. Gupta. 1993. Adjuvants: a balance between toxicity and adjuvanticity. Vaccine 11: 293-306.
4. Lindblad, E. B. 2004. Aluminium adjuvants: in retrospect and prospect. Vaccine 22: 3658-3668.
5. McCluskie, M. J., and R. D. Weeratna. 2001. Novel adjuvant systems. Curr. Drug Targets Infect. Disord. 1: 263-271.
6. Weissburg, R. P., P. W. Herman, J. L. Cleland, D. Eastman, F. Farina, S. Frie, A. Lim, J. Mordenti, T. T. Nguyen, and M. R. Peterson. 1995. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum. Pharm. Res. 12: 1439-1446.
7. 14C-labeled tetanus toxoid. Vaccine 14: 1412-1416.
8. Ramanathan, V. D., P. Badenoch-Jones, and J. L. Turk. 1979. Complement activation by aluminum and zirconium compounds. Immunology 37: 881-888.
9. White, R. G., A. H. Coons, and J. M. Connolly. 1955. Studies on antibody production. III. The alum granuloma. J. Exp. Med. 102: 73-82.
10. Naim, J. O., C. J. van Oss, W. Wu, R. F. Giese, and P. A. Nickerson. 1997. Mechanisms of adjuvancy: I-Metal oxides as adjuvants. Vaccine 15: 1183-1193.
11. Sun, H., K. G. Pollock, and J. M. Brewer. 2003. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21: 849-855.
12. Lindblad, E. B. 2006. Are mineral adjuvants triggering TLR2/TLR4 on dendritic cells by a secondary cascade reaction in vivo through the action of heat shock proteins and danger signals? Vaccine 24: 697-698.
13. Dinarello, C. A. 2002. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20: S1-S13.
14. Reed, S. G., D. L. Pihl, P. J. Conlon, and K. H. Grabstein. 1989. IL-1 as adjuvant: role of T cells in the augmentation of specific antibody production by recombinant human IL-1α. J. Immunol. 142: 3129-3133.
15. + T cells. J. Immunol. 159: 591-598.
16. Martinon, F., and J. Tschopp. 2005. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26: 447-454.
17. Ogura, Y., F. S. Sutterwala, and R. A. Flavell. 2006. The inflammasome: first line of the immune response to cell stress. Cell 126: 659-662.
18. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
19. Martinon, P., V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
20. Re, P., and J. L. Strominger. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276: 37692-37699.
21. Li, H., S. Nookala, X. R. Bina, J. E. Bina, and F. Re. 2006. Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J. Leukocyte Biol. 80: 766-773.
22. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
23. Kurt-Jones, E. A., S. Hamberg, J. Ohara, W. E. Paul, and A. K. Abbas. 1987. Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J. Exp. Med. 166: 1774-1787.
24. Weaver, C. T., C. M. Hawrylowicz, and E. R. Unanue. 1988. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. USA 85: 8181-8185.
25. Huber, M., H. U. Beuscher, P. Rohwer, R. Kurrle, M. Rollinghoff, and M. Lohoff. 1998. Costimulation via TCR and IL-1 receptor reveals a novel IL-1́-mediated autocrine pathway of Th2 cell proliferation. J. Immunol. 160: 4242-4247.
26. Mannhalter, J. W., H. O. Neychev, G. J. Zlabinger, R. Ahmad, and M. M. Eibl. 1985. Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin. Exp. Immunol. 61: 143-151.
27. Xu, D., V. Trajkovic, D. Hunter, B. P. Leung, K. Schulz, J. A. Gracie, I. B. McInnes, and F. Y. Liew. 2000. IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur. J. Immunol. 30: 3147-3156.
28. Pollock, K. G., M. Conacher, X. Q. Wei, J. Alexander, and J. M. Brewer. 2003. Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 108: 137-143.
29. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950.
30. + human blood mononuclear cells. J. Clin. Invest. 101: 711-721.